Your browser doesn't support javascript.
loading
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA.
Zu, Yingling; Zhou, Jian; Fu, Yuewen; Fang, Baijun; Liu, Xinjian; Zhang, Yanli; Yu, Fengkuan; Zuo, Wenli; Zhou, Hu; Gui, Ruirui; Li, Zhen; Liu, Yanyan; Zhao, Huifang; Zhang, Chengjuan; Song, Yongping.
Afiliación
  • Zu Y; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Zhou J; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China. zhoujiandoctor@163.com.
  • Fu Y; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Fang B; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Liu X; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Zhang Y; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Yu F; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Zuo W; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Zhou H; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Gui R; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Li Z; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Liu Y; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Zhao H; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Zhang C; Center of Bio-Repository, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China.
  • Song Y; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, 450000, People's Republic of China. songyongping001@126.com.
Sci Rep ; 11(1): 253, 2021 01 08.
Article en En | MEDLINE | ID: mdl-33420287
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Acondicionamiento Pretrasplante / Ciclofosfamida / Trasplante de Células Madre de Sangre Periférica / Trasplante de Células Madre Mesenquimatosas / Enfermedad Injerto contra Huésped / Anemia Aplásica Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Acondicionamiento Pretrasplante / Ciclofosfamida / Trasplante de Células Madre de Sangre Periférica / Trasplante de Células Madre Mesenquimatosas / Enfermedad Injerto contra Huésped / Anemia Aplásica Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article